ROGER HOLT: Open Payments
NPI 1518143817 · LEXINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 27 payments from 7 companies in 2025. Trend: 2023 $999 · 2024 $745 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 12 | $236 |
| Teva Pharmaceuticals USA, Inc. | 5 | $117 |
| Alkermes, Inc. | 5 | $104 |
| ABBVIE INC. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $26 |
| E.R. Squibb & Sons, L.L.C. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: INGREZZA, AUSTEDO XR, ARISTADA, VRAYLAR, CAPLYTA, COBENFY, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
